FilingSEC EDGAR8-K
TriSalus Life Sciences Receives FDA 510(k) Clearance for TriNav Advance
· SEC accepted
StageFDA Clearance
Filing content
The company received FDA 510(k) clearance for its TriNav Advance device for liver embolization and plans to commence commercialization.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…